Bond Eli Lilly 3.7% ( US532457BJ65 ) in USD
| Issuer | Eli Lilly | ||||||||
| Market price | |||||||||
| Country | United States
|
||||||||
| ISIN code |
US532457BJ65 ( in USD )
|
||||||||
| Interest rate | 3.7% per year ( payment 2 times a year) | ||||||||
| Maturity | 01/03/2045 | ||||||||
|
Prospectus brochure in PDF format |
|||||||||
| Minimal amount | 2 000 USD | ||||||||
| Total amount | 800 000 000 USD | ||||||||
| Cusip | 532457BJ6 | ||||||||
| Standard & Poor's ( S&P ) rating | A+ ( Upper medium grade - Investment-grade ) | ||||||||
| Moody's rating | A1 ( Upper medium grade - Investment-grade ) | ||||||||
| Next Coupon | 01/09/2026 ( In 5 days ) | ||||||||
| Detailed description |
Eli Lilly and Company is a global pharmaceutical company specializing in the research, development, manufacturing, and marketing of pharmaceutical products and biologicals. The Bond issued by Eli Lilly ( United States ) , in USD, with the ISIN code US532457BJ65, pays a coupon of 3.7% per year. The coupons are paid 2 times per year and the Bond maturity is 01/03/2045 The Bond issued by Eli Lilly ( United States ) , in USD, with the ISIN code US532457BJ65, was rated A1 ( Upper medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by Eli Lilly ( United States ) , in USD, with the ISIN code US532457BJ65, was rated A+ ( Upper medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||||
| |||||||||
Français
Italiano
United States